-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VmJ8lLHozDkXo6mrsmfD9OvGi+9JzsftWvf6lT7pqFAO4D2HtFJVqxxfs05D9UwN nVA+bCSpPCEfAD6KtKP9WQ== 0001171843-07-000409.txt : 20070727 0001171843-07-000409.hdr.sgml : 20070727 20070727135027 ACCESSION NUMBER: 0001171843-07-000409 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070726 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20070727 DATE AS OF CHANGE: 20070727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19974 FILM NUMBER: 071005957 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763 8-K 1 f8k_072707.htm FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.   20549
 
______________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 

 
Date of Report (Date of earliest event reported) July 26, 2007

 
ICU MEDICAL, INC.
(Exact name of registrant as specified in its charter)
 
 
DELAWARE
0-19974
33-0022692
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

 
951 Calle Amanecer, San Clemente, California
92673
(Address of principal executive offices)
(Zip Code)

 
 
(949) 366-2183
Registrant’s telephone number, including area code


N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
INFORMATION TO BE INCLUDED IN THE REPORT

 
Item 1.01      Entry Into a Material Definitive Agreement
 
On July 26, 2007, the Board of Directors approved an employment agreement with Dr. Lopez, President and Chief Executive Officer, for the period January 1, 2007 through December 31, 2007.  Except for the change in the Initial Term from the year 2006 to the year 2007, the terms of employment remain unchanged from the employment agreement for the year 2006, which is filed as Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2006.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  July 27, 2006

                                                           ICU MEDICAL, INC.



                                                           /s/ Francis J. O’Brien
                                                           Francis J. O'Brien
                                                           Secretary, Treasurer and
                                                           Chief Financial Officer
 

 
 -----END PRIVACY-ENHANCED MESSAGE-----